Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in BEAM — Beam Therapeutics Inc.

CIK 923093 STAMFORD, CT

Position in BEAM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,684,837
+$557,440 QoQ
Shares Held
49,092
+3.8% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#90
of 274 holders
Holding Since
Jun 2021
14 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in BEAM Over Time

Shares Held

Position Value (USD)

Derivatives in BEAM

reported options exposure · as of Sep 30, 2025
CallValue
$536,367
CallShares
22,100
PutValue
$827,607
PutShares
34,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. BEAM ranks #41 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BEAM

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,684,837 49,092
2026-03-31 $1,127,397 47,310
2025-12-31 $449,258 16,207
2025-09-30 $827,607 34,100
2025-09-30 $536,367 22,100
2025-06-30 $428,652 25,200
2025-06-30 $788,889 46,378
2024-12-31 $411,060 16,575
2024-09-30 $804,016 32,817
2024-06-30 $1,148,585 49,022
2024-03-31 $1,580,798 47,845
2023-06-30 $217,794 6,821
2022-09-30 $1,945,569 40,839
2022-03-31 $430,781 7,518
2021-09-30 $4,087,207 46,974
2021-06-30 $675,212 5,246